Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.54+0.00 (+0.51%)

Close on Nov 13, 2026Market cap $14.69MP/E –Yield –

Citius Pharmaceuticals statistics

63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 12, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $14.69M; $272.32M
Enterprise Value: $313.39M; $146.23M
PB Ratio: 0.22; 2.00
P/TBV Ratio: 0.26; 2.22

Share statisticsIndustry

Shares Outstanding: 27M; 58M
Shares Change (YoY): 64.5%; 10.8%
Shares Change (QoQ): 22.7%; 0.50%
Float: 27M; 49M
Shares Held by Insiders: 3.04%; 11.7%
Shares Held by Institutions: 4.96%; 56.4%

Short sellingIndustry

Short Interest: 6M; –
Short Interest Change: 1.17%; -0.80%
Short % of Float: 21.7%; 9.01%
Short % of Shares Outstanding: 21.0%; 6.30%
Days to Cover: 17.76; 5.15

Stock price statisticsIndustry

52-Week High: $1.54; –
52-Week Low: $0.37; –
20-Day Moving Average: $0.50; –
50-Day Moving Average: $0.52; –
200-Day Moving Average: $0.64; –
Average True Range (14): $0.06; –
Price Change (1 Week): -1.83%; -1.15%
Price Change (1 Month): 16.3%; -4.87%
Price Change (3 Months): -4.79%; -21.0%
Price Change (6 Months): -23.6%; -20.6%
Price Change (YTD): -31.1%; -23.6%
Price Change (1 Year): -51.6%; -22.4%
Price Change (3 Years): -97.2%; -29.5%
Price Change (5 Years): -98.8%; -77.9%
Price Change (10 Years): -99.7%; -65.4%
Average Volume (10 Days): 274,463; –
Average Volume (20 Days): 312,048; –
Average Volume (90 Days): 457,665; –
Relative Volume: 0.38; 0.70
Relative Strength Index (14): 53.4; 43.4
Volatility (1 Year): 108.8%; 80.1%
Beta (5 Years): 1.54; 1.07

Returns on capitalIndustry

Return on Invested Capital (ROIC): -8.51%; -32.9%
Return on Capital Employed (ROCE): -42.5%; -37.9%

Financial positionIndustry

Current Ratio: 0.84; 3.30
Quick Ratio: 0.34; 2.39
Debt / Equity: 4.60; 0.49
Interest Coverage: -143.87; -6.35

EfficiencyIndustry

Employee Count: 23; 74
WACC: 4.43%; 10.2%

Income statement (TTM)Industry

Operating Income: -$38.53M; -$21.37M
Pretax Income: -$38.68M; -$12.95M
EBITDA: -$38.53M; -$17.21M
EPS (Diluted): -$3.38; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $17.01M; $68.68M
Total Debt: $306.41M; $116.91M
Net Cash (Debt): -$289.40M; $17.76M
Net Cash Per Share: -$10.54; $0.80
Equity (Book Value): $66.61M; $53.89M
Book Value Per Share: $2.43; $1.50
Tangible Book Value: $57.27M; $27.13M
Working Capital: -$8.32M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$26.55M; -$12.38M

Dividends and yieldsIndustry

Buyback Yield: -219.9%; -0.76%
Shareholder Yield: -219.9%; 0.00%

Taxes and interestIndustry

Interest Expense: $267.78K; $2.90M
Income Tax: $1.06M; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -3.56; 0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CTXR	S&P 500	Difference	CTXR per year	S&P 500 per year
1 month	+12.4%	-3.0%	+15.5 pts
3 months	-27.1%	-2.8%	−24.3 pts
Year to date	-31.1%	+11.5%	−42.6 pts
1 year	-47.0%	+13.5%	−60.5 pts
3 years	-97.2%	+77.7%	−174.9 pts	-69.5%	+21.1%
5 years	-98.8%	+72.6%	−171.4 pts	-58.9%	+11.5%
10 years	-99.7%	+308.2%	−407.8 pts	-43.8%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M CTXR shares were sold short on Oct 30, 2026, up 1.2% from the previous report, or 21.66% of the shares available to trade. At recent volumes it would take 17.8 days to buy them back. Over the last 20 sessions, 57.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	5,764,914	+1.2%	324,581	17.8
Oct 15, 2026	5,698,085	+2.0%	188,299	30.3
Sep 30, 2026	5,588,997	+0.5%	183,104	30.5
Sep 15, 2026	5,561,090	-1.3%	202,404	27.5
Aug 31, 2026	5,631,567	+4.9%	929,505	6.1
Aug 14, 2026	5,366,929	+4.0%	1,009,099	5.3
Jul 31, 2026	5,158,044	+3.5%	624,952	8.3
Jul 15, 2026	4,981,669	+4.6%	191,281	26.0
Jun 30, 2026	4,763,787	-2.5%	203,199	23.4
Jun 15, 2026	4,883,551	-1.3%	331,496	14.7
May 29, 2026	4,948,323	-4.2%	895,810	5.5
May 15, 2026	5,163,523	-1.9%	756,952	6.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?